吉安县| 陈仓| 彭水| 新宁| 尖扎| 怀远| 茌平| 大同县| 乌拉特后旗| 梁河| 和田| 缙云| 沁水| 上林| 台东| 隆安| 若尔盖| 洱源| 英吉沙| 阿荣旗| 长岛| 克什克腾旗| 宁波| 石屏| 兰西| 乌当| 万年| 阿荣旗| 洋山港| 敦煌| 益阳| 精河| 岳西| 桦甸| 沙坪坝| 苍南| 驻马店| 资兴| 巴彦| 绵竹| 聊城| 范县| 红岗| 奉节| 新和| 响水| 长白山| 无锡| 宜州| 天峻| 鲁山| 钟山| 吉木萨尔| 长丰| 绥中| 明溪| 修文| 汉南| 金湾| 黄石| 东安| 宝安| 都昌| 新河| 辽源| 长乐| 托克托| 盐池| 花莲| 淮滨| 喀喇沁左翼| 长泰| 宕昌| 乌海| 昂仁| 乡城| 湘乡| 密云| 肇东| 大姚| 泸州| 雄县| 德保| 潼南| 蒙阴| 惠农| 封丘| 延川| 富县| 尤溪| 剑河| 龙胜| 勐腊| 周村| 合江| 红古| 漾濞| 乌苏| 若尔盖| 五指山| 普兰店| 黄岩| 兴和| 穆棱| 武穴| 丹阳| 万年| 信宜| 阿克塞| 朗县| 威县| 铜梁| 浏阳| 湖南| 平安| 大兴| 隆德| 余庆| 太原| 普宁| 双峰| 连云区| 香格里拉| 绥江| 望都| 夹江| 芜湖县| 株洲县| 穆棱| 蕉岭| 莱芜| 宜州| 盂县| 沽源| 海盐| 左云| 无为| 宿州| 化州| 庆安| 东兴| 交口| 内黄| 衡阳县| 那曲| 邻水| 甘南| 五营| 肥乡| 濉溪| 嵩县| 吴江| 石门| 宜章| 南昌市| 常州| 西和| 全南| 沧州| 惠水| 潞城| 英吉沙| 剑川| 班玛| 延寿| 交城| 峡江| 通州| 四会| 西青| 吉木萨尔| 合江| 嘉禾| 陵川| 铜鼓| 达县| 孝义| 天峻| 新安| 建昌| 栾城| 荔浦| 公安| 江门| 河源| 滕州| 大城| 台州| 泽州| 南华| 高唐| 南华| 平顺| 临潭| 京山| 甘南| 永州| 盐都| 云林| 通河| 大厂| 南浔| 红原| 江都| 西山| 怀宁| 泸西| 定兴| 益阳| 固原| 密云| 白云矿| 上海| 沿滩| 云龙| 施甸| 科尔沁右翼中旗| 富蕴| 昌吉| 乌当| 调兵山| 瓮安| 江夏| 乌兰察布| 石林| 冷水江| 珠穆朗玛峰| 太仆寺旗| 东光| 新巴尔虎左旗| 蛟河| 潮阳| 商都| 单县| 平湖| 彭山| 塔河| 轮台| 遂昌| 甘谷| 霍邱| 师宗| 酒泉| 罗平| 乐山| 镇安| 开封县| 昌都| 如东| 祥云| 广平| 孙吴| 阳原| 南芬| 嫩江| 蚌埠| 周至| 云安| 锦屏| 新青| 西峡| 桐梓| 克拉玛依| 织金| 宠物论坛
Global EditionASIA 中文双语Fran?ais
Opinion
Home / Opinion / Op-Ed Contributors

Joining tech frontiers to improve healthcare

By Tej Kohli | China Daily | Updated: 2019-09-20 08:09
武汉论坛 70年来筚路蓝缕、风雨兼程,中国人民的奋斗不仅让神州大地处处焕发生机,也开辟了一条不同于西方的现代化路径,让古老的中华民族巍然屹立于世界东方。 武汉女人 随后,还举行了“己亥年周文王祭祀大典”活动,嘉宾们参观了庆祝新中国成立70周年周易书画展、海峡两岸及海外周易文化交流30年成果展、周易文化创意产品暨非遗文化产品展等。 宠物论坛 已取得国广国际在线网络(北京)有限公司使用授权的被授权人,应严格在授权范围内使用,不得超范围使用,使用时应注明“来源:国际在线”。 武汉论坛 塘花 论坛资讯 铁杆镇 武汉论坛 泰兴路

Artificial intelligence (AI) and biotechnology both are on an exponential growth trajectory, and have the potential to improve how we experience our lives, even to extend life itself. But few have considered how these two frontier technologies could be brought together symbiotically to tackle global health and environmental challenges.

Consider the pace of recent developments in both fields. Biotechnology, in cost-benefit terms, has been improving by a factor of 10 every year. The cost of deciphering the human genome has dropped from $3 billion in 2001 to about $1,000 today-a process that took months 10 years ago can now be completed in less than an hour.

Likewise, based on current developments, PricewaterhouseCoopers estimates that AI's contribution to global output will reach $15.7 trillion by 2030-more than the current combined output of China and India.

Yet, if anything, these predictions underestimate the economic impact. AI applications will eventually be so broad and so embedded in every aspect of our daily lives that they will likely contribute three to four times more to global output than the internet, which today accounts for about $50 trillion of the global economy.

Moreover, the siloed nature of current analyses means that potential AI-biotech combination technologies have not been fully considered or priced in. For example, combination technologies could tackle a global health issue such as organ donation. According to the World Health Organization, an average of about 100,800 solid organ transplants were performed each year until of 2008. Yet in the United States alone, nearly 113,000 people are waiting for a life-saving organ transplant, while thousands of good organs are discarded each year.

For years, those in need of a kidney transplant had limited options: they either had to find a willing and biologically viable living donor, or wait for a viable deceased donor to show up in their local hospital.

But with enough patients and willing donors, Big Data and AI-through a system of paired kidney donation-make it possible to facilitate far more matches than the one-to-one system allows. Patients can now get a donor who is not a biological fit and still receive a kidney, because AI can match donors to recipients across a massive array of patient-donor relationships. In fact, a single person who steps forward to donate a kidney-either to a loved one or a stranger-can set off a domino effect that saves dozens of lives by resolving the missing link in a long chain of pairings.

Since the first paired kidney exchanges took place in 2000, nearly 6,000 people have received kidney transplants from donors identified by algorithms. But this could be just the start of AI-facilitated organ transplantation. AI can already identify potential donors and recipients; in the future, it will be able to account for even richer patient data, perhaps including moral and religious factors, to help with sequencing and triage decisions (that is, determining whether someone should get a transplant before someone else).

The biggest hurdle preventing these AI models from reaching their full potential is biological. In theory, AI applications could draw on data sets encompassing all living and deceased organ donors and all patients worldwide. But, in practice, there is a time limitation on most organ pairings, because organs from deceased donors are viable for transplantation for only a short period. To be paired, recipients must be located within a geographic radius that can be reached in time.

Synthetic biotechnology could vastly expand the scope of feasible pairings. Globally, the synthetic biology market is growing fast and is expected to exceed $12.5 billion by 2024, reflecting a compound annual growth rate of 20 percent. Within this emerging industry, there are companies (including one in which I am an investor) exploring methods of preserving and even regenerating organs outside of the body, potentially for multiple days at an ambient temperature. This could extend the distances that organs can be transported, thus enabling a network effect by increasing the size of viable data pools from which AI models can draw to produce more efficient chains of pairings.

Perfecting new biotechnologies usually takes years. But, if successful, these innovations could revolutionize large areas of public health, with the global organ-donation regime being just the start.

Yet the moral and ethical implications of today's frontier technologies are far-reaching. Fundamental questions have to be addressed. How will algorithms weigh the needs of poor and wealthy patients? Should a donor organ be sent to a distant patient-potentially one in a different country-with a low rejection risk or to a nearby patient whose rejection risk is only slightly higher?

These are indeed important questions.

But the matching power of AI means that eight lives could be saved by just one deceased organ donor; innovations in biotechnology could ensure that organs are never wasted. The faster these technologies advance, the more lives we can save.

AI and biotech are undergoing rapid development precisely because they have such far-reaching potential. As they move forward, we must keep looking for new combinations to unlock, because by considering them in isolation, we would underestimate their potential.

The author is a London-based technology and real estate entrepreneur.

Project Syndicate

The views don't necessarily represent those of China Daily.

  
Most Viewed in 24 Hours
China Views
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
顺港楼 阿拉善左旗 宜川四村 罗庄村委会 保利红棉花园 山上乡 辰中村 清明桥新村 宝塔山村
聂拉木 建阳市 伦敦路 浙江富阳市受降镇 孔氏乡 浙江萧山区新湾镇 匡家 小纱帽 荷清苑社区
天长市 大风凹 平山道先进里 磁县 江苏张家港市南丰镇 小眉 翰苑村 天地公 东八村 如来古洞
https://www.whr.cc/bbsitemap.htm